These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 15130951

  • 1. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
    Kanwar JR, Kanwar RK, Krissansen GW.
    Brain; 2004 Jun; 127(Pt 6):1313-31. PubMed ID: 15130951
    [Abstract] [Full Text] [Related]

  • 2. Glutamate excitotoxicity in a model of multiple sclerosis.
    Pitt D, Werner P, Raine CS.
    Nat Med; 2000 Jan; 6(1):67-70. PubMed ID: 10613826
    [Abstract] [Full Text] [Related]

  • 3. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL, Wolak K, Fournier S, David S.
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis.
    Gold BG, Voda J, Yu X, McKeon G, Bourdette DN.
    J Neurosci Res; 2004 Aug 01; 77(3):367-77. PubMed ID: 15248293
    [Abstract] [Full Text] [Related]

  • 6. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-alpha and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE).
    Penkowa M, Hidalgo J.
    Exp Neurol; 2001 Jul 01; 170(1):1-14. PubMed ID: 11421579
    [Abstract] [Full Text] [Related]

  • 7. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.
    J Autoimmun; 2011 Nov 01; 37(3):228-41. PubMed ID: 21752599
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-inflammatory immunotherapy for multiple sclerosis/experimental autoimmune encephalomyelitis (EAE) disease.
    Kanwar JR.
    Curr Med Chem; 2005 Nov 01; 12(25):2947-62. PubMed ID: 16378498
    [Abstract] [Full Text] [Related]

  • 11. Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule-1, given early in the course of disease progression.
    Kanwar JR, Kanwar RK, Wang D, Krissansen GW.
    Immunol Cell Biol; 2000 Dec 01; 78(6):641-5. PubMed ID: 11114975
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
    Li FQ, Sempowski GD, McKenna SE, Laskowitz DT, Colton CA, Vitek MP.
    J Pharmacol Exp Ther; 2006 Sep 01; 318(3):956-65. PubMed ID: 16740622
    [Abstract] [Full Text] [Related]

  • 13. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L, Gonzalez Deniselle MC, Gierman L, Meyer M, Lima A, Roig P, De Nicola AF.
    Neuroimmunomodulation; 2008 Sep 01; 15(1):76-83. PubMed ID: 18667803
    [Abstract] [Full Text] [Related]

  • 14. 2-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity.
    Wang P, Wang ZW, Lin FH, Han Z, Hou ST, Zheng RY.
    Biochem Biophys Res Commun; 2011 Mar 04; 406(1):152-7. PubMed ID: 21303658
    [Abstract] [Full Text] [Related]

  • 15. Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis.
    Parvaneh Tafreshi A.
    Iran J Allergy Asthma Immunol; 2006 Dec 04; 5(4):177-81. PubMed ID: 17237570
    [Abstract] [Full Text] [Related]

  • 16. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ.
    Glia; 2006 May 04; 53(7):696-703. PubMed ID: 16498619
    [Abstract] [Full Text] [Related]

  • 17. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis.
    Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E, Gini B, Bach SD, Martinello M, Bifari F, Galiè M, Turano E, Budui S, Sbarbati A, Krampera M, Bonetti B.
    Stem Cells; 2009 Oct 04; 27(10):2624-35. PubMed ID: 19676124
    [Abstract] [Full Text] [Related]

  • 18. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.
    Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, Gerhardt E, Neumann H, Sendtner M, Lühder F, Gold R.
    Brain; 2010 Aug 04; 133(Pt 8):2248-63. PubMed ID: 20826430
    [Abstract] [Full Text] [Related]

  • 19. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
    Savino C, Pedotti R, Baggi F, Ubiali F, Gallo B, Nava S, Bigini P, Barbera S, Fumagalli E, Mennini T, Vezzani A, Rizzi M, Coleman T, Cerami A, Brines M, Ghezzi P, Bianchi R.
    J Neuroimmunol; 2006 Mar 04; 172(1-2):27-37. PubMed ID: 16337691
    [Abstract] [Full Text] [Related]

  • 20. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation.
    Linker RA, Mäurer M, Gaupp S, Martini R, Holtmann B, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R.
    Nat Med; 2002 Jun 04; 8(6):620-4. PubMed ID: 12042814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.